Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:EDGE

Edge Therapeutics (EDGE) Stock Price, News & Analysis

Edge Therapeutics logo

About Edge Therapeutics Stock (NASDAQ:EDGE)

Advanced Chart

Key Stats

Today's Range
$41.29
$41.29
50-Day Range
$0.50
$6.71
52-Week Range
$0.28
$17.38
Volume
15 shs
Average Volume
373,201 shs
Market Capitalization
$1.30 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive EDGE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Edge Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

EDGE Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

EDGE Stock Analysis - Frequently Asked Questions

Edge Therapeutics, Inc. (NASDAQ:EDGE) announced its quarterly earnings results on Thursday, November, 1st. The biotechnology company reported ($0.11) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.16.

Based on aggregate information from My MarketBeat watchlists, some other companies that Edge Therapeutics investors own include ContraFect (CFRX), McEwen (MUX), Arena Pharmaceuticals (ARNA), BioLineRx (BLRX), Bristol Myers Squibb (BMY), Cerecor (CERC) and CRISPR Therapeutics (CRSP).

Company Calendar

Last Earnings
11/01/2018
Today
8/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:EDGE
CIK
1472091
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$40.86 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-81.29%
Return on Assets
-56.92%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
5.59
Quick Ratio
5.59

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.95 per share
Price / Book
43.46

Miscellaneous

Outstanding Shares
31,510,000
Free Float
N/A
Market Cap
$1.30 billion
Optionable
Not Optionable
Beta
3.65
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NASDAQ:EDGE) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners